Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis.

Guillaume Pineton de Chambrun,Aurélien Amiot,Guillaume Bouguen,Stéphanie Viennot,Romain Altwegg,Edouard Louis,Michael Collins,Mathurin Fumery,Florian Poullenot,Laura Armengol,Anthony Buisson,Vered Abitbol,David Laharie,Philippe Seksik,Stéphane Nancey,Pierre Blanc,Yoram Bouhnik,Benjamin Pariente,Laurent Peyrin-Biroulet

Clinical Gastroenterology and Hepatology（2020）

引用 22|浏览72

暂无评分

摘要

In a retrospective study of 104 patients with refractory UP, anti-TNF therapy induced clinical remission in 50% and mucosal healing in 60%. About two thirds of the patients were still receiving anti-TNF therapy at 2 years.

查看译文

关键词

Inflammatory Bowel Disease,Second-Line Treatment,Immune Suppression,Trial,Proctitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要